These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 25366108)
1. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Sisignano M; Baron R; Scholich K; Geisslinger G Nat Rev Neurol; 2014 Dec; 10(12):694-707. PubMed ID: 25366108 [TBL] [Abstract][Full Text] [Related]
2. [Neuropathic pain caused by the toxic effect of chemotherapy in patients with malignant neoplasms]. Chubykina SV; Tatarinova MU; Avakyan GG Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):7-12. PubMed ID: 37315236 [TBL] [Abstract][Full Text] [Related]
3. Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy-induced neuropathy. Al-Mazidi S; Alotaibi M; Nedjadi T; Chaudhary A; Alzoghaibi M; Djouhri L Eur J Pain; 2018 Apr; 22(4):810-821. PubMed ID: 29282807 [TBL] [Abstract][Full Text] [Related]
4. Huachansu suppresses TRPV1 up-regulation and spinal astrocyte activation to prevent oxaliplatin-induced peripheral neuropathic pain in rats. Hao Y; Luo X; Ba X; Wang J; Zhou S; Yang S; Fang C; Jiang C; Sun W Gene; 2019 Jan; 680():43-50. PubMed ID: 30244138 [TBL] [Abstract][Full Text] [Related]
5. TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain. Aloi VD; Pinto SJPC; Van Bree R; Luyten K; Voets T; Vriens J Pain; 2023 Sep; 164(9):2060-2069. PubMed ID: 37079852 [TBL] [Abstract][Full Text] [Related]
6. Preventing oxaliplatin-induced neuropathic pain: Using berberine to inhibit the activation of NF-κB and release of pro-inflammatory cytokines in dorsal root ganglions in rats. Ni W; Zheng X; Hu L; Kong C; Xu Q Exp Ther Med; 2021 Feb; 21(2):135. PubMed ID: 33376517 [TBL] [Abstract][Full Text] [Related]
7. [The molecular mechanism of oxaliplatin-induced peripheral neuropathic pain]. Yang SM; Wu SB; Wu JM; Huang JB; Huang MJ; Xiong DL; Hao Y; Sun WP; Xiao LZ Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(43):3581-3587. PubMed ID: 34808752 [No Abstract] [Full Text] [Related]
8. Ropivacaine-loaded hydrogels for prolonged relief of chemotherapy-induced peripheral neuropathic pain and potentiated chemotherapy. Qing X; Dou R; Wang P; Zhou M; Cao C; Zhang H; Qiu G; Yang Z; Zhang J; Liu H; Zhu S; Liu X J Nanobiotechnology; 2023 Dec; 21(1):462. PubMed ID: 38041074 [TBL] [Abstract][Full Text] [Related]
9. Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain. Sisignano M; Angioni C; Park CK; Meyer Dos Santos S; Jordan H; Kuzikov M; Liu D; Zinn S; Hohman SW; Schreiber Y; Zimmer B; Schmidt M; Lu R; Suo J; Zhang DD; Schäfer SM; Hofmann M; Yekkirala AS; de Bruin N; Parnham MJ; Woolf CJ; Ji RR; Scholich K; Geisslinger G Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12544-12549. PubMed ID: 27791151 [TBL] [Abstract][Full Text] [Related]
10. Effect of Aromatherapy Massage on Chemotherapy-Induced Peripheral Neuropathic Pain and Fatigue in Patients Receiving Oxaliplatin: An Open Label Quasi-Randomized Controlled Pilot Study. Izgu N; Ozdemir L; Bugdayci Basal F Cancer Nurs; 2019; 42(2):139-147. PubMed ID: 29200001 [TBL] [Abstract][Full Text] [Related]
11. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain. Liang X; Yu G; Su R Eur J Pharmacol; 2018 Mar; 823():27-34. PubMed ID: 29408090 [TBL] [Abstract][Full Text] [Related]
12. New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment. Majithia N; Loprinzi CL; Smith TJ Oncology (Williston Park); 2016 Nov; 30(11):1020-9. PubMed ID: 27854104 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. Lynch ME; Cesar-Rittenberg P; Hohmann AG J Pain Symptom Manage; 2014 Jan; 47(1):166-73. PubMed ID: 23742737 [TBL] [Abstract][Full Text] [Related]
15. Distinguishing analgesic drugs from non-analgesic drugs based on brain activation in macaques with oxaliplatin-induced neuropathic pain. Shidahara Y; Natsume T; Awaga Y; Ogawa S; Yamoto K; Okamoto S; Hama A; Hayashi I; Takamatsu H; Magata Y Neuropharmacology; 2019 May; 149():204-211. PubMed ID: 30817933 [TBL] [Abstract][Full Text] [Related]
16. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Xiao WH; Bennett GJ Pain; 2012 Mar; 153(3):704-709. PubMed ID: 22244441 [TBL] [Abstract][Full Text] [Related]
17. Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy. Kim JH; Dougherty PM; Abdi S Gynecol Oncol; 2015 Mar; 136(3):453-9. PubMed ID: 25584767 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy. Sałat K Pharmacol Rep; 2020 Jun; 72(3):486-507. PubMed ID: 32394362 [TBL] [Abstract][Full Text] [Related]
20. A Randomized Controlled Trial to Assess the Effectiveness of Muscle Strengthening and Balancing Exercises on Chemotherapy-Induced Peripheral Neuropathic Pain and Quality of Life Among Cancer Patients. Dhawan S; Andrews R; Kumar L; Wadhwa S; Shukla G Cancer Nurs; 2020; 43(4):269-280. PubMed ID: 30888982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]